An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors

Clinical trial NCT06568614 · TERMINATED

Trial details

NCT number: NCT06568614
Sponsor: BeOne Medicines
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic MTAP-deleted Solid Tumors

Start date: 2024-10-12
Primary completion: 2026-04-13
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.